T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Is a
Allocation Type
NA
0
Participating Facility
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
autologous EBV specific CTLs
0
Intervention Type
Biological
0
Last Updated
October 10, 2012
0
Masking Type
None (Open Label)
0
Primary Completion Date
2007
0
Trial Recruitment Size
25
0
Trial Sponsor
Clinical Trial Start Date
2001
0
Study Completion Date
2012
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Administration of EBV-Specific T-Lymphocytes to Patients With EBV-Positive Nasopharyngeal Carcinoma
0
Official Website
Find more entities like T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.